EyeGate Pharms

EYEG NASDAQ
0.2268
-0.0025
-1.11%
After Hours: 0.2200 -0.0068 -2.98% 16:17 07/19 EDT
Open
0.2221
Prev Close
0.2293
High
0.2425
Low
0.2200
Volume
244.56K
Avg Vol (3M)
530.09K
52 Week High
0.8600
52 Week Low
0.2100
% Turnover
0.54%
Market Cap
10.33M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers EyeGate Pharms EYEG stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Eyegate Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company. The Company is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The Company's lead product, EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone phosphate, which is delivered into the ocular tissues through its drug delivery system, the EyeGate II Delivery System. The Company is developing EGP-437 for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and/or ciliary body, and macular edema, an abnormal thickening of the macula associated with the accumulation of excess fluids in the extracellular space of the neurosensory retina. The EyeGate II Delivery System is designed to deliver optimal quantities of drugs to the anterior or posterior segments of the eye.
MORE >

Recently

Name
Price
%Change